Evidence map›Paper›PMID 41064589›Full record

ArticleJournal of pharmaceutical policy and practice2025

An ideological playground? Changes in community pharmacy ownership - a case study from four Nordic and Baltic countries.

Katri Hämeen-Anttila, Anna Birna Almarsdóttir, Daisy Volmer, Ingunn Björnsdottir, Sofia Kälvemark Sporrong

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katri Hämeen-AnttilaSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.ORCID https://orcid.org/0000-0002-3515-0792
Anna Birna AlmarsdóttirDepartment of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
Daisy VolmerInstitute of Pharmacy, University of Tartu, Tartu, Estonia.
Ingunn BjörnsdottirDepartment of Pharmacy, University of Oslo, Oslo, Norway.
Sofia Kälvemark SporrongDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0001-5848-8625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pharmacy systems have undergone fundamental changes in some Nordic and Baltic countries: Iceland, Norway, Sweden and Estonia. The political declared aims of the reforms have included increasing competition and/or effectiveness of the pharmacy market and the availability of medicines or pharmacies. The aim of this commentary is to describe the policy measures taken in these countries changing community pharmacy ownership, the arguments and rationales behind, and the evidence of the intended and unintended outcomes. Furthermore, we discuss the lessons learned for social pharmacy researchers. The aim of increasing the availability of pharmacies has been achieved, if interpreted as more pharmacies. However, the number of pharmacies has increased, mainly in urban areas, with a need to assure the availability of pharmacies in rural areas with regulations and/or subsidies in some countries. There were also unintended consequences. The aim to increase competition and diversity failed, as big domestic and foreign pharmacy chains conquered most of the pharmacy market. Learning for researchers in social pharmacy when studying pharmacy system changes includes considering the social, economic, and political reality in which the sector exists. The intended and unintended consequences of changes need a multi-method approach, often mixing quantitative (epidemiology and economics) and qualitative social science methods. Lastly, if we want evidence-based policymaking, we as researchers need to do better in communicating our research evidence to politicians and to the public.

Indexed as

EstoniaownershipPharmaceutical policypharmaciesScandinavian and Nordic countries

Identifiers

PMID41064589
PMCPMC12502118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.